Prime Medicine Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $8.14 on 06/12/24, with the lowest value being $1.11 on 05/22/25.
52-week price history of PRME Stock
A stock’s 52-week high and low prices can reveal a great deal about its present condition and potential future performance. Prime Medicine Inc’s current trading price is -83.67% away from its 52-week high, while its distance from the 52-week low is 19.82%. The stock’s price range during this period has fluctuated between $1.11 and $8.14. Shares of the company, which operates in the Healthcare sector, recorded a trading volume of around 1.25 million for the day, which was evidently lower than the average daily volume of 1.85 million over the last three months.
Financial Performance and Market Capitalization
Prime Medicine Inc (PRME) has experienced a quarterly decline of -39.68% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 174.62M and boasts a workforce of 214 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 2.0208, with a change in price of -1.9500. Similarly, Prime Medicine Inc recorded 1,532,375 in trading volume during the last 100 days, posting a change of -59.45%.
PRME Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for PRME stands at 1.13. Similarly, the long-term debt-to-equity ratio is also 1.07.
PRME Stock Stochastic Average
Prime Medicine Inc’s raw stochastic average for the past 50 days is currently at 22.00%. This represents a fall from the raw stochastic average of the last 20 days, which was recorded at 43.14%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 22.08% and 18.11%, respectively.
PRME Stock Price Performance Analysis
Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The index has shown a price loss of -54.45% this year. Over the last six months, there has been a stronger performance of -59.70%. The price of PRME leaped by -20.83% during the last 30 days period. For the last 5-days stocks have improved 4.72%.
